Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

bioAffinity Technologies (BIAF) Return on Invested Capital (2022 - 2025)

Historic Return on Invested Capital for bioAffinity Technologies (BIAF) over the last 4 years, with Q3 2025 value amounting to 2.94%.

  • bioAffinity Technologies' Return on Invested Capital fell 9800.0% to 2.94% in Q3 2025 from the same period last year, while for Sep 2025 it was 2.94%, marking a year-over-year decrease of 9800.0%. This contributed to the annual value of 1.89% for FY2024, which is 9700.0% down from last year.
  • As of Q3 2025, bioAffinity Technologies' Return on Invested Capital stood at 2.94%, which was down 9800.0% from 89.14% recorded in Q2 2025.
  • bioAffinity Technologies' Return on Invested Capital's 5-year high stood at 0.24% during Q4 2022, with a 5-year trough of 89.14% in Q2 2025.
  • Moreover, its 4-year median value for Return on Invested Capital was 1.48% (2024), whereas its average is 8.85%.
  • In the last 5 years, bioAffinity Technologies' Return on Invested Capital crashed by -8700bps in 2023 and then tumbled by -875300bps in 2025.
  • bioAffinity Technologies' Return on Invested Capital (Quarter) stood at 0.24% in 2022, then crashed by -363bps to 1.12% in 2023, then crashed by -115bps to 2.39% in 2024, then decreased by -23bps to 2.94% in 2025.
  • Its last three reported values are 2.94% in Q3 2025, 89.14% for Q2 2025, and 3.43% during Q1 2025.